Epicutaneous Immunotherapy for Aeroallergen and Food Allergy

IgE-mediated allergies today affect up to 30 % of the population in industrialized countries. Allergen immunotherapy is the only disease-modifying treatment option with a long-term effect. However, very few patients (<5 %) choose immunotherapy, due to the long treatment duration (between 3–5 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Senti, Gabriela, von Moos, Seraina, Kündig, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Specific Immunotherapy (L Cox, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025904/
https://www.ncbi.nlm.nih.gov/pubmed/24918342
http://dx.doi.org/10.1007/s40521-013-0003-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025904/
https://www.ncbi.nlm.nih.gov/pubmed/24918342
http://dx.doi.org/10.1007/s40521-013-0003-8

Ejemplares similares